415-389-4670655 Redwood Highway #395, Mill Valley, California 94941
TwitterFacebookLinkedin
Liviakis Financial Communications Inc.Liviakis Financial Communications Inc.
Liviakis Financial Communications Inc.
Comprehensive Investor Relations Services in partnership with growth companies
  • HOME
  • ABOUT LIVIAKIS
  • SERVICES
  • CORPORATE PORTFOLIO
  • NEWS
    • COMPANY NEWS
    • OUR BLOG
  • CONTACT
Menu back  
COMPANY NEWS
Date Name
DescAsc

Energy Fuels Announces 2018 Results

PR Newswire•March 12, 2019 LAKEWOOD, CO, March 12, 2019 /PRNewswire/ – Energy Fuels Inc. (NYSE American: UUUU; TSX: EFR) (“Energy Fuels” or the “Company”), today reported its financial results for the year ended December 31, 2018. The Company’s Annual Report on Form 10-K has been filed with the U.S. Securities and Exchange Commission (“SEC”), and may…

Details
March 12, 2019

Energy Fuels Advancing Vanadium Acitivities; Strengthens Cash Position

Denver, Colorado – June 28, 2018 Energy Fuels Inc. (NYSE American: UUUU; TSX: EFR) (“Energy Fuels” or the “Company”), a leading producer of uranium and vanadium in the United States, is pleased to announce that it recently strengthened its cash position and currently has sufficient existing cash on hand to allow the Company the ability…

Details
June 28, 2018

CURE Pharmaceutical to Showcase Company Growth at the 8th LD Micro Invitational

LOS ANGELES, May 23, 2018 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 8th annual LD Micro Invitational on Monday, June 4th at 4 PM PT/ 7 PM ET at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. CEO Rob…

Details
May 23, 2018

CURE Pharmaceutical to Present on the Increased Bioavailability for Cannabinoids Due to New Delivery Technologies at O’Cannabiz Conference

GlobeNewswire•June 5, 2018 LOS ANGELES, June 05, 2018 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced that CEO Rob Davidson will be presenting at the O’Cannabiz Conference & Expo on June 9 at 2:50 PM ET in Toronto, Canada. Davidson will discuss “Maximizing and Understanding the Benefits of…

Details
June 5, 2018

CURE Pharmaceutical to Present at the 9th Annual LD Micro Invitational

GlobeNewswire•May 30, 2019 LOS ANGELES, May 30, 2019 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 9th Annual LD Micro Invitational on Wednesday, June 5th at 11:40 a.m. PT at the Luxe Sunset Boulevard Hotel in Los Angeles. The conference will…

Details
May 30, 2019

CURE Pharmaceutical to Present at the 12th Annual LD Micro Main Event Investor Conference

GlobeNewswire•December 5, 2019 CURE CEO to discuss company’s expanded technology platform and pharmaceutical pipeline LOS ANGELES, Dec. 05, 2019 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 12th Annual LD Micro Main Event on Wednesday, December 11 at 9:45 AM PST/…

Details
December 5, 2019

Cure Pharmaceutical to Present at the “Planet MicroCap Showcase 2019”

GlobeNewswire•April 30, 2019 CURE CEO to discuss expanded product pipeline and company’s continued execution into cannabinoid market. LAS VEGAS, April 30, 2019 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced that it will be presenting at the Planet MicroCap Showcase at 8:30 a.m. on Wednesday, May 1, 2019…

Details
April 30, 2019

CURE Pharmaceutical to Acquire Privately-Held Chemistry Holdings Inc., Expanding Its Technology Platform in Oral Drug Delivery

GlobeNewswire•April 1, 2019 OXNARD, Calif., April 01, 2019 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR) (“CURE”), an innovative drug delivery and development company, today announced that it has agreed to acquire Chemistry Holdings Inc. (“Chemistry Holdings”, “CH”), a formulation technology company that is developing innovative delivery systems for a variety of industries, in an all-stock transaction.…

Details
April 1, 2019
1
23
…45678…
9
10
Prev pageNext page
COMPANY & BLOG UPDATES
RECENT NEWS
  • Wealth Minerals to Present at the LD Micro Main Event (XII) December 6, 2019
  • CURE Pharmaceutical to Present at the 12th Annual LD Micro Main Event Investor Conference December 5, 2019
  • CURE Pharmaceutical Names Canopy Rivers’ Chairman, John K. Bell, To Board of Directors November 19, 2019
  • CURE Pharmaceutical Takes First Step to Acquire Coeptis Pharmaceuticals and its Combination Drug for Osteoarthritis Pain and Hypertension November 14, 2019
  • Wealth Minerals Provides Corporate Update November 12, 2019
CONTACT US
Phone: 415-389-4670
Fax: 415-389-4694
655 Redwood Highway #395
 Mill Valley, California 94941

Our privacy policy
COMPANY NEWS
  • Wealth Minerals to Present at the LD Micro Main Event (XII)
    December 6, 2019
  • CURE Pharmaceutical to Present at the 12th Annual LD Micro Main Event Investor Conference
    December 5, 2019
ABOUT LIVIAKIS
  • Testimonials
  • Press
  • Philanthropy
SITEMAP
  • About Liviakis
  • Services
  • Corporate Portfolio
  • Company News
  • Contact
Liviakis Financial Communications Inc.
©2015 Liviakis Financial | All Rights Reserved

Website Design: Hi 5 Studio | Video Production: Mav Media